Palabras claves: immunotherapy, long-term survival, non–small cell lung cancer, survival mixture models
Autores: Alfonso S., Carmen Elena Viada, Lage Davila A., Luaces P.L.o., Muchene L., Neninger Vinageras E., Rodríguez P.C., Sánchez L., Shkedy Z., Tania Crombet